Lawyers making closing arguments in the securities fraud trial of ex-pharmaceutical executive Martin Shkreli on Thursday painted contrasting portraits of investors who were allegedly defrauded by the so-called “Pharma Bro.”
The lead prosecutor in the case, which is in its fifth week of trial, cast them as victims of lies fed to them by Shkreli to keep their money wrapped up in an elaborate Ponzi scheme, while the head of Shkreli’s defense team repeatedly emphasized that the investors ultimately made profits and dismissed the testimony of some as “rich people B.S.”
